CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on August 30, 2006
Clinical Journal of the American Society of Nephrology
© 2006 American Society of Nephrology
doi: 10.2215/CJN.01220406
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.01220406v1
1/6/1191    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juergensen, E.
Right arrow Articles by Finkelstein, F. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juergensen, E.
Right arrow Articles by Finkelstein, F. O.

Received April 13, 2006
Accepted on August 4, 2006

ORIGINAL ARTICLES

Hemodialysis and Peritoneal Dialysis: Patients’ Assessment of Their Satisfaction with Therapy and the Impact of the Therapy on Their Lives

Erika Juergensen , Diane Wuerth , Susan H. Finkelstein , Peter H. Juergensen , Ambek Bekui , and Fredric O. Finkelstein 1

Hospital of St. Raphael, Yale University and the Renal Research Institute, New Haven, Connecticut


1 To whom correspondence should be addressed. E-mail: fof{at}comcast.net.


   Abstract

This study was undertaken to examine patient satisfaction with peritoneal dialysis (PD) and hemodialysis (HD) therapies, focusing attention on the positive and negative impact of the therapies on patients’ lives. Patients were recruited from a free-standing PD unit and two free-standing HD units. A total of 94% (n = 62) of eligible PD and 84% (n = 84) of eligible HD patients participated. HD patients were significantly older and had higher Charlson Comorbidity Index scores than the PD patients, but there were no differences in duration of dialysis treatment, prevalence of diabetes, educational backgrounds, or home situations. Patients were asked to rate their overall satisfaction with and the overall impact of their dialysis therapy on their lives, using a 1 to 10 Likert scale. In addition, patients were asked to rate the impact of their therapy on 15 domains that had been cited previously as being important for patients’ quality of life. The mean satisfaction score for PD patients (8.02 ± 1.41) was higher than for HD patients (7.4 ± 1.4; P = 0.15). PD patients indicated that there was less impact of the dialysis treatment on their lives globally (7.25 ± 2.12 versus 6.19 ± 2.83; P = 0.019). In addition, PD patients noted less impact of the therapy in 14 of the 15 domains examined. With the use of a proportional odds model analysis, the only significant predictor of overall satisfaction and impact of therapy was dialysis modality (P = 0.037 and P = 0.021, respectively). Patients also were asked to comment freely on the positive and negative effects of the dialysis treatments on their lives, and a taxonomy of patient perceptions and concerns was developed. This study suggests that PD patients in general are more satisfied with their overall care and believe that their treatment has less impact on their lives than HD patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Society of Nephrology.